Lipid-based amphotericin B formulations: from animals to man
Authors:
- Ihor BekerskyIBIhor Bekersky
- Robert M FieldingRFRobert M Fielding
- Donald BuellDBDonald Buell
- Ira LawrenceILIra Lawrence
- 1 June 1999
- journal article
- Published by Elsevier in Pharmaceutical Science & Technology Today
- Vol. 2 (6) , 230-236
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993
- In vivo evaluation of the effect of the size and opsonization on the hepatic extraction of liposomes in rats: An application of Oldendorf methodBiopharmaceutics & Drug Disposition, 1992
- Amphotericin BPostgraduate Medicine, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- New Spectrum of Fungal Infections in Patients with CancerClinical Infectious Diseases, 1989
- Treatment of systemic fungal infections: Recent progress and current problemsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- The emergence of fungi as major hospital pathogensJournal of Hospital Infection, 1988
- Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteinsBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- INTRODUCTORY REMARKSAnnals of the New York Academy of Sciences, 1978
- Fungal Sterols and the Mode of Action of the Polyene Antibiotics1974